February 25, 2021 – Orna Therapeutics has launched with $80 million in series A financing to develop a new version of messenger RNA (mRNA) therapies conceived in Daniel Anderson’s lab at Massachusetts Institute of Technology.
February 25, 2021 – Orna Therapeutics has launched with $80 million in series A financing to develop a new version of messenger RNA (mRNA) therapies conceived in Daniel Anderson’s lab at Massachusetts Institute of Technology.